skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of cancer protein biomarkers using proteomic techniques

Abstract

The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.

Inventors:
; ;
Issue Date:
Research Org.:
Yale Univ., New Haven, CT (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1493331
Patent Number(s):
10,168,334
Application Number:
15/268,134
Assignee:
Yale University (New Haven, CT) CHO
DOE Contract Number:  
FG02-ER63462
Resource Type:
Patent
Resource Relation:
Patent File Date: 2016 Sep 16
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Mor, Gil G., Ward, David C., and Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States: N. p., 2019. Web.
Mor, Gil G., Ward, David C., & Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States.
Mor, Gil G., Ward, David C., and Bray-Ward, Patricia. Tue . "Identification of cancer protein biomarkers using proteomic techniques". United States. https://www.osti.gov/servlets/purl/1493331.
@article{osti_1493331,
title = {Identification of cancer protein biomarkers using proteomic techniques},
author = {Mor, Gil G. and Ward, David C. and Bray-Ward, Patricia},
abstractNote = {The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2019},
month = {1}
}

Patent:

Save / Share:

Works referenced in this record:

Use of serum prolactin for monitoring the therapeutic response in ovarian malignancy
journal, September 1991

  • Jha, P.; Farooq, A.; Rao, D. L.
  • International Journal of Gynecology & Obstetrics, Vol. 36, Issue 1, p. 33-38
  • DOI: 10.1016/0020-7292(91)90175-5

Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
journal, April 2002

  • Kim, Jae-Hoon; Skates, Steven J.; Uede, Toshimitsu
  • JAMA, Vol. 287, Issue 13, p. 1671-1679
  • DOI: 10.1001/jama.287.13.1671

Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer
journal, December 2003

  • Mathur, Subbi P.; Mathur, Rajesh S.; Underwood, Paul B.
  • Gynecologic Oncology, Vol. 91, Issue 3, p. 486-493
  • DOI: 10.1016/j.ygyno.2003.08.023

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
journal, October 2004


Serum protein markers for early detection of ovarian cancer
journal, May 2005

  • Mor, G.; Visintin, I.; Lai, Y.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 21, p. 7677-7682
  • DOI: 10.1073/pnas.0502178102

Serum tumor markers in colorectal cancer staging, grading, and follow-up
journal, August 1996


Multiplexed protein profiling on microarrays by rolling-circle amplification
journal, April 2002

  • Schweitzer, Barry; Roberts, Scott; Grimwade, Brian
  • Nature Biotechnology, Vol. 20, Issue 4, p. 359-365
  • DOI: 10.1038/nbt0402-359

Cancer screening in a high risk population: a clinical trial
journal, April 2001


Ovarian cancer screening
journal, August 2003

  • Urban, Nicole; McIntosh, Martin W.; Andersen, Marin (Robyn)
  • Hematology/Oncology Clinics of North America, Vol. 17, Issue 4, p. 989-1005
  • DOI: 10.1016/S0889-8588(03)00063-7

The role of Osteopontin in tumor metastasis
journal, October 2004


Differential Gene Expression in Chemically Induced Mouse Lung Adenomas
journal, January 2003


Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin level
journal, October 1998

  • Yoshida, Masumi; Koshiyama, Masafumi; Konishi, Mitsunaga
  • European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 81, Issue 1, p. 123-128
  • DOI: 10.1016/S0301-2115(98)00162-6